Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination

Vaccine-associated cerebral venous thrombosis has become an issue following the extensive vaccination program of the Coronavirus Disease of 2019 (COVID-19) Vaccine AstraZeneca (ChAdOx1 vaccine). The importance of early diagnosis should be emphasized due to the high mortality rate without appropriate...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Che-Yu, Tsai, Shi-Hung, Fan, Ju-Sing, Lin, Yu-Kai, Kao, Chih-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265178/
https://www.ncbi.nlm.nih.gov/pubmed/34274191
http://dx.doi.org/10.1016/j.ajem.2021.07.011
Descripción
Sumario:Vaccine-associated cerebral venous thrombosis has become an issue following the extensive vaccination program of the Coronavirus Disease of 2019 (COVID-19) Vaccine AstraZeneca (ChAdOx1 vaccine). The importance of early diagnosis should be emphasized due to the high mortality rate without appropriate treatment. Young female populations in western countries have been reported to be at a greater risk of this vaccine related thrombotic event, but cases in East Asia are lacking. Herein, we present the first case of cerebral venous sinus thrombosis 10 days after ChAdOx1 vaccination in a middle-age Asian male in Taiwan.

Ejemplares similares